Meiwu Technology Co Ltd

On August 20, 2026, Xiamen Chunshang Health Technology Co., Ltd (“Xiamen Chunshang”), a wholly owned subsidiary of Meiwu Technology Company Limited (the “Company”), entered into an equity transfer agreement (the “Agreement”) with Xiamen Hemeitong Commercial Co., Ltd. (“Xiamen Hemeitong”), and two shareholders of Xiamen Hemeitong (the “Sellers”) to acquire 100% equity interests of Xiamen Hemeitong (the “Acquisition”). Pursuant to the Agreement, the Company agreed to pay an aggregate of RMB23,520,000 (approximately $35,000,000) in cash as consideration upon closing.

The Company engaged Beijing Yingyue Asset Appraisal Co., Ltd., an independent valuation advisor, to provide a valuation report with regard to the equity interests of Xiamen Hemeitong. According to the valuation report issued by Beijing Yingyue Asset Appraisal Co., Ltd. on August 17, 2026, the 100% equity interests of Xiamen Hemeitong worth RMB 239,405,140 (approximately $35,283,952) as of June 30, 2026. The closing of the Acquisition is subject to certain customary closing conditions.

The descriptions of the Agreement herein are qualified in its entirety by reference to the Agreement, which is filed as Exhibit 10.1 to this Form 6-K.

As outlined in the Company’s annual report on From 20-F for the fiscal year ended December 31, 2025, the Company aims to build a comprehensive online ecosystem integrating upstream brand owners’ skincare product research and development and sales, midstream distributors and retailors’ support and training, downstream franchisee partnerships and end-users consumers. The management recognized the widespread application of AI tools in various industries in China and determined that, to maintain the Company’s competitiveness, the Company started investing in the develop of “MOBO”, an AI-assisted platform that combines consumer-facing skincare services, e-commerce functions, data analytics, and operational tools for business clients (“MOBO App”). The consumer facing function of this app is intended to provide comprehensive skincare solutions of evaluation, diagnosis, product recommendation, follow-up and projected results to consumers. The e-commerce function of this app is to assist brand owners, distributors, retailors, beauty salons and other B-end beauty industry clients in evaluating consumer demand, product performance and skincare trends through AI assisted data analysis and insights generated by the AI tools on the platform.

Xiamen Hemei is a distributor of the functional skincare products in Southern and Eastern regions in China with access to approximately 1,600 brand owners, retailors and beauty salons in Southern and Eastern regions in China. The management of the Company believes that, once the Acquisition is completed, Xiamen Hemeitong’s network could bring great amount of business clients to the MOBO App, facilitate broader adoption of its MOBO App and accelerate the collection of user interaction data, therefore, assist in the continued development and refinement of the MOBO App’s functionality and services.

Below is a diagram that illustrates the Company’s corporate structure immediately prior to the closing of the Acquisition:

Below is a diagram that illustrates the Company’s corporate structure immediately after the closing of the Acquisition: